Results 141 to 150 of about 59,823 (200)

Glioblastoma With a Primitive Neuronal Component: A Case Report and Review of the Literature. [PDF]

Cureus
Omichi R, Nakajo K, Tanoue Y, Tsujino N, Kohashi K, Ichinose T, Goto T.   +6 more
europepmc   +1 more source

Hypoxia Increases Connexin46 and Connexin43 Levels in KNS-42 Glioblastoma Cells. [PDF]

Int J Mol Sci
Minogue PJ, Beyer EC, Berthoud VM.
europepmc   +1 more source

Advances in glioblastoma: Is there light at the end of the tunnel? [PDF]

Indian J Med Res
Chaturvedi A, Poodipedi SC.
europepmc   +1 more source

IL-37 drives temozolomide resistance in glioblastoma via MAPK pathway activation. [PDF]

Oncol Lett
Wang Y, Liu Y, Wang J, Rong W, Song X.
europepmc   +1 more source

PART as a Negative Outcome Modifier of Glioblastoma Treatment, Case Report. [PDF]

NeuroSci
Terada R, Dailey J, Yan S, Punsoni M, Wong ET.   +4 more
europepmc   +1 more source

A blood-brain barrier model based on flexible tubes to tailor the biophysical and chemical environment for drug delivery testing. [PDF]

Mater Today Bio
Alexaki M, Marino A, Lefevre MC, Canale C, Odino D, Mano JF, Oliveira MB, Ciofani G.   +7 more
europepmc   +1 more source

Generation of Heterotypic Primary Human Spheroids from Glioblastoma Resections and (Pre-)Clinical Applications. [PDF]

Cells
Wiener SE, Conrad J, Javid S, Gieß S, Jägersberg M, Krenzlin H, Keric N, Régnier-Vigouroux A, Geiß C.   +8 more
europepmc   +1 more source

Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas. [PDF]

Neuro Oncol
Schiff D, Ye X, Li J, Ellingson BM, Wen PY, Walbert T, Campian J, Nabors LB, Ozer BH, Desai A, Omuro A, Desideri S, Danda N, Grossman S, Bindra RS.   +14 more
europepmc   +1 more source

Pancreatic Neuroendocrine Tumor in Lynch Syndrome: Expanding the Tumor Spectrum of Mismatch Repair Deficiency. [PDF]

Cureus
Mudupula Vemula SS, Sanka S, Natarajan V, Varghese MT, Isaac D.   +4 more
europepmc   +1 more source